Precision Medicine News and Research

RSS

Researchers investigate how genetic data can be made accessible in medical practice

In a project funded by the Austrian Science Fund FWF, a research group from Vienna investigated how genetic data can be made accessible in medical practice in order to improve the safety and effectiveness of medication.

10 Jul 2018

New TSPO-targeted PET imaging more fully evaluates extent of rheumatoid arthritis

A new positron emission tomography imaging method more fully evaluates the extent of rheumatoid arthritis by targeting translocator protein expression in the synovium (joint lining tissue).

10 Jul 2018

New technique paves way for safer medicines without side effects

A new technique for precisely targeting molecules within cells is paving the way for safer medicines that are free of side effects.

9 Jul 2018

New nanoparticle-based platform for detecting esophageal cancer cells

Researchers at the University of Texas at Arlington's College of Nursing and Health Innovation have developed a new nanoparticle-based platform for simultaneous imaging and treatment of esophageal cancer.

6 Jul 2018

3D Printing Technology and Personalized Medicine

In this interview Dr. Serajuddin, Professor of Industrial Pharmacy at St John's University talks about personalized medicine and 3D printing technology.

From Thermo Fisher Scientific – Pharmaceutical and Biopharmaceutical Solutions 6 Jul 2018

Scientists take a deep dive into differences between Zika and dengue virus

More than two years after reports of skyrocketing Zika rates surfaced worldwide, questions still loom about this complicated virus.

6 Jul 2018

Internet-based support system found to be effective in improving weight loss

In a randomized long-term lifestyle change trial, an Internet-based health behavior change support system was effective in improving weight loss and reduction in waist circumference for up to 2 years. The findings are published in the Journal of Internal Medicine.

5 Jul 2018

OGT announces direct sales and support services in Europe

Oxford Gene Technology, The Molecular Genetics Company, has announced that it is now directly selling Cytocell Fluorescence In Situ Hybridisation products through several established affiliates of SysmexCorporation in Europe following its acquisition last year.

From Oxford Gene Technology 4 Jul 2018

Mount Sinai study identifies potential new treatment target for aggressive bladder cancer

A potential new target for treatment has been identified in an aggressive form of bladder cancer, Mount Sinai researchers report.

4 Jul 2018

LLNL employs high-performance computing for better understanding of TBI

Since the wars in Afghanistan and Iraq began in 2001, more than 350,000 cases of traumatic brain injury in servicemen and women have been reported to the Department of Defense.

3 Jul 2018

New method separates circulating tumor cells from blood samples using sound waves

Using sound waves, an international team of researchers has developed a gentle, contact-free method for separating circulating tumor cells from blood samples that is fast and efficient enough for clinical use.

3 Jul 2018

New biomarker paves way for personalized bladder cancer treatments

Researchers have identified a potential new target for the treatment of a particularly aggressive form of bladder cancer, in the form of microRNA.

2 Jul 2018

Streamlining and translating basic science discoveries into the clinic

To make sure that good ideas to enhance healthcare are not lost due to a lack of resources, a growing number of centers at Penn Medicine organize forums to pitch ideas to improve medical devices and technology, hold annual competitions to fund studies to improve patient care while keeping costs down, and sponsor seed grants for programs focused on patients who need individualized tailoring of their treatment.

2 Jul 2018

Pulmonx announces FDA approval of Zephyr Endobronchial Valve to treat severe emphysema

Pulmonx Corp. announced today that the U.S. Food and Drug Administration has approved the Zephyr Endobronchial Valve System for treating severe emphysema patients.

30 Jun 2018

Individuals may react differently to environmental chemicals based upon genetic profile

Why do individuals respond differently to the same environment? Researchers from North Carolina State University and Oregon State University have pinpointed a genetic difference in zebrafish tied to differing responses to the same environmental chemical.

30 Jun 2018

Study shows precision medicine improves outcomes in pancreatic cancer patients

A study published today by the Pancreatic Cancer Action Network, Perthera, Inc., and colleagues in the AACR journal Clinical Cancer Research found for the first time that precision medicine can improve outcomes and provide clinically meaningful information to pancreatic cancer patients.

28 Jun 2018

Rethinking current method paves way for new, personalized cancer diagnostics

All diseases have a genetic component. Advances in understanding the genetic mechanisms behind these disease enables the development of early diagnostic tests, new treatments, or interventions to prevent disease onset or minimize disease severity.

28 Jun 2018

UPMC and Pitt announce launch of advanced genome sequencing center

UPMC and the University of Pittsburgh today announced the launch of an advanced genome sequencing center to support clinical diagnostics and research initiatives in precision medicine and immunotherapy.

27 Jun 2018

Study shows benefits, safety of long-lasting radionuclide therapy for patients with advanced NETs

A first-in-human study presented at the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging demonstrates the benefits and safety of a new, long-lasting type of radionuclide therapy for patients with advanced, metastatic neuroendocrine tumors.

26 Jun 2018

Study finds byproduct of common prostate cancer drug can stimulate growth of tumor cells

A genetic anomaly in certain men with prostate cancer may impact their response to common drugs used to treat the disease, according to new research at Cleveland Clinic. The findings may provide important information for identifying which patients potentially fare better when treated with an alternate therapy.